Kuros Biosciences Expands into Extremities Markets

In English: https://www.bio-technopark.ch/en/news-en/kuros-biosciences-expands-into-extremities-markets/
Auf Deutsch: https://www.bio-technopark.ch/news/kuros-biosciences-erweitert-angebot-auf-alle-gliedmassen/

InSphero Awarded Major EU Grant to Address Diversity in 3D In Vitro Testing

In English: https://www.bio-technopark.ch/en/news-en/insphero-awarded-major-eu-grant-to-address-diversity-in-3d-in-vitro-testing/
Auf Deutsch: https://www.bio-technopark.ch/news/insphero-erhaelt-eu-foerderung-fuer-3d-in-vitro-tests/

Valneva and LimmaTech Announce First Vaccination in Phase 2b Study

In English: https://www.bio-technopark.ch/en/news-en/valneva-and-limmatech-announce-first-vaccination-in-phase-2b-human-challenge-study-of-tetravalent-shigella-vaccine-candidate-s4v2/

Auf Deutsch: https://www.bio-technopark.ch/news/limmatech-und-valneva-fuehren-erste-shigellose-impfung-durch/

DINAMIQS opens new lab in Schlieren

In English
Auf Deutsch

Molecular Partners Presents Preclinical Proof-of-Concept

In English